Background: Valsartan is an established drug for treatment of essential hypertension. It
blocks the action of Angiotensin II irrespective of its sources. A large proportion of patients …

Background: Studies across the world have demonstrated the efficacy of valsartan in
lowering blood pressure in a variety of patient populations, several of them investigated …

Objective: This study compared the efficacy and tolerability of two combination regimens of
valsartan and hydrochlorothiazide (HCTZ) with valsartan monotherapy in patients with …

Introduction Previous studies have demonstrated that hypertensive patients need
concomitant therapy with one or more drugs from different classes of antihypertensive …

In this randomized, double-blind study, 126 mild to moderate essential hypertensive patients
from northern China were studied to determine the efficacy and safety of a combination …

Objectives: To assess the efficacy of valsartan in a different ethnic population than that
studied in international trials. Also to compare the adverse experiences reported in this trial …

Objective: Most patients with severe hypertension are at high risk for cardiovascular events
and require prompt blood pressure (BP)-lowering and combination therapy to achieve BP …

The long-term safety data on angiotensin II receptor blockers in combination with thiazide
diuretics are limited. The present study reports on the long-term efficacy, safety, and …

An open label, optional titration trial to evaluate the efficacy, tolerability and safety of
Valsartan 80mg od/Valsartan 160mg od in patients with mild to moderate hypertension …

This patient data meta‐analysis included 9 randomized, double‐blind, placebo‐controlled
trials (N= 4278) of once‐daily valsartan 80, 160, or 320 mg or valsartan/hydrochlorothiazide …